Diagnosis, Dual (Psychiatry) Clinical Trial
Official title:
Dual Diagnosis Inpatients: Telephone Monitoring RCT to Improve Outcomes
Verified date | May 2015 |
Source | VA Office of Research and Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
This research program will improve the care and treatment outcomes of dually diagnosed veterans who receive inpatient psychiatry care, and decrease their use of VA inpatient mental health services. It will increase the use of substance abuse outpatient care and 12-step groups to benefit recovery, reduce rehospitalizations, and reduce costs for VA.
Status | Active, not recruiting |
Enrollment | 270 |
Est. completion date | June 2015 |
Est. primary completion date | June 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Dually diagnosed veteran in VA inpatient psychiatry treatment Exclusion Criteria: - Current diagnosis of schizophrenia or schizoaffective disorder - too psychiatrically unstable or cognitively impaired to understand informed consent and other study procedures - does not have ongoing telephone access |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
United States | VA Ann Arbor Healthcare System, Ann Arbor, MI | Ann Arbor | Michigan |
United States | VA Palo Alto Health Care System, Palo Alto, CA | Palo Alto | California |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development |
United States,
Timko C, Bonn-Miller MO, McKellar JD, Ilgen MA. Detoxification history and two-year outcomes of substance use disorder treatment and mutual-help group participation. Journal of drug issues. 2014 Jan 1; 44(1):4-21.
Timko C, Cronkite RC, McKellar J, Zemore S, Moos RH. Dually diagnosed patients' benefits of mutual-help groups and the role of social anxiety. J Subst Abuse Treat. 2013 Feb;44(2):216-23. doi: 10.1016/j.jsat.2012.05.007. Epub 2012 Jul 3. — View Citation
Woodhead E, Cowden Hindash A, Timko C. Dual Diagnosis, Mutual-Help Use, and Outcomes: A Naturalistic Follow-Up. Journal of Dual Diagnosis. 2013 May 3; 9(2):158-164.
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Use of substance use disorder continuing care and 12-step mutual help groups | One-year post-intervention | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00583440 -
12-step Facilitation for the Dually Diagnosed
|
Phase 1/Phase 2 | |
Completed |
NCT00237822 -
Increasing Treatment Adherence in Co-Occurring Psychiatric and Drug Use Disorders
|
Phase 2 | |
Not yet recruiting |
NCT04442776 -
Dual Integrated Attention Program (DAIP) in People With Severe Dual Diagnosis
|
N/A | |
Completed |
NCT05103865 -
Animal-Assisted Therapy in the Residential Treatment of Schizophrenia and Addictions
|
N/A | |
Not yet recruiting |
NCT05115266 -
Efficacy of Animal-assisted Therapy in Patients With Borderline Personality Disorder and Addictions.
|
N/A |